drugset / Trial / NCT06972498
A Prospective Multicenter Study: Ivosimab + Chemotherapy as Neoadjuvant for Resectable pMMR/MSS CRC Liver Mets
Phase 2
Not yet recruiting
35 enrolled
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Zhejiang University · collab
NaSingle-groupOpen-labelTreatment
Summary
The population receiving ivosimab combined with chemotherapy for neoadjuvant treatment of colorectal cancer liver metastasis.
Timeline
- Start
- 2025-07-01
- Primary completion
- 2027-12-30
- Completion
- 2027-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ivosimab | Unknown | — | — |